Business Strategy Asian Leader Global Niche

• Thriving to become one of the world leaders in

botanical drugs by tapping into the wealth of Chinese

herbal medicines.

• Integrating the development process of botanical new

drugs, from valid new drug candidate identification,

ingredient sourcing, regulatory agency approval,

manufacturing, to marketing and sales, with a

geographical emphasis in Asia.

• Cooperating with international partners in

developing and marketing of our new drugs in the

global market.

Corporate Profile

PhytoHealth Corporation, a member company of

Maywufa Biopharma Group, was incorporated in 1998 as

a new drug development company with focus on novel

botanical drugs.

The company has achieved remarkable milestones since

its inception and has received various major national

awards and government grants in recognition of its

achievements in both technical innovations and

pharmaceutical product developments.

PhytoHealth successfully held its initial public offering

(IPO) in 2002, being the first new drug development

company to be listed on Taiwan stock market.